Inventor · disambiguated record
Joseph Schwarz
Also filed as: SCHWARZ JOSEPH · SCHWARZ JOSEPH R
12 granted patents·33 pending applications·864 citations·filing 1993–2025
93Inventor score
Top patents by PatentIndex Score
45 records- 0198US5514670ASubmicron emulsions for delivery of peptidesPHARMOS CORP·Filed 1993·Granted May 7, 1996·474 cites·39 claims
- 0296US5993846ABioadhesive emulsion preparations for enhanced drug deliveryPHARMOS CORP·Filed 1998·Granted Nov 30, 1999·199 cites·20 claims
- 0390US7153888B2Stabilization of benzoyl peroxide in solutionALPHARX INC·Filed 2004·Granted Dec 26, 2006·31 cites·13 claims
- 0488US7781429B2Vehicle for topical delivery of anti-inflammatory compoundsALPHARX INC·Filed 2006·Granted Aug 24, 2010·13 cites·11 claims
- 0586US7138394B2Vehicle for topical delivery of anti-inflammatory compoundsALPHARX INC·Filed 2002·Granted Nov 21, 2006·20 cites·21 claims
- 0686US6764997B2Stabilized azithromycin compositionsTEVA PHARMA·Filed 2002·Granted Jul 20, 2004·29 cites·59 claims
- 0785US8277070B1Counter with border lightingSCHWARZ JOSEPH R·Filed 2009·Granted Oct 2, 2012·33 cites·24 claims
- 0885US6117415AToothpaste comprising bioadhesive submicron emulsion for improved delivery of antibacterial and anticaries agentsALPHARX INC·Filed 1999·Granted Sep 12, 2000·62 cites·13 claims
- 0970US8097646B2Ophthalmic preparation containing menthyl ester of indomethacinSCHWARZ JOSEPH·Filed 2006·Granted Jan 17, 2012·2 cites·6 claims
- 1064US11289067B2Voice generation based on characteristics of an avatarIBM·Filed 2019·Granted Mar 29, 2022·1 cites·20 claims
- 1161US2011070305A1Sustained release pharmaceutical composition containing mebicarALPHARX INC·Filed 2009·Application pending·0 cites
- 1259US2010099775A1Method for ameliorating of post-anesthetic recoveryALPHARX INC·Filed 2008·Application pending·0 cites
- 1359US2005158348A1Vehicle for topical delivery of anti-inflammatory compoundsALPHARX INC·Filed 2005·Application pending·0 cites
- 1458US2005106239A1Stabilized azithromycin compositionsFiled 2004·Application pending·0 cites
- 1557US2009169635A1Pharmaceutical compositions and use thereofALPHARX INC·Filed 2007·Application pending·0 cites
- 1657US2004192622A1Stabilized azithromycin compositionsFiled 2004·Application pending·0 cites
- 1756US2007042009A1Topical composition for delivery of salicylatesSCHWARZ JOSEPH·Filed 2006·Application pending·0 cites
- 1856US2008102127A1Hybrid lipid-polymer nanoparticulate delivery compositionGAO HAI Y·Filed 2007·Application pending·0 cites
- 1955US2003072798A1Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereofALPHARX INC·Filed 2002·Application pending·0 cites
- 2055US2005037073A1Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereofALPHARX INC·Filed 2004·Application pending·0 cites
- 2155US2010215725A1Pharmaceutical composition containing idebenone for the treatment of liver disordersSCHWARZ JOSEPH·Filed 2009·Application pending·0 cites
- 2255US2025186339A1Composition for intraoral delivery of biologically active peptides and proteinsSCHWARZ JOSEPH·Filed 2025·Application pending·0 cites
- 2354US2023058895A1Physiologically acceptable eutectic mixtures of cannabidiolSCHWARZ JOSEPH·Filed 2022·Application pending·0 cites
- 2454US2010130619A1Pharmaceutical composition for parenteral administration of idebenoneSCHWARZ JOSEPH·Filed 2008·Application pending·0 cites
- 2553US2005255133A1Topical composition for acne treatmentALPHARX INC·Filed 2004·Application pending·0 cites
- 2652US12246087B2Composition for intraoral delivery of biologically active peptides and proteinsPHARCON INC·Filed 2016·Granted Mar 11, 2025·0 cites·7 claims
- 2752US2007042007A1Topical composition for delivery of salicylate estersSCHWARZ JOSEPH·Filed 2005·Application pending·0 cites
- 2851US2009060993A1Solid pharmaceutical composition for enhanced delivery of coenzyme q-10 and ubiquinonesSCHWARZ JOSEPH·Filed 2007·Application pending·0 cites
- 2951US2002102301A1Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereofFiled 2000·Application pending·0 cites
- 3051US2009061009A1Composition and Method of Treatment of Bacterial InfectionsSCHWARZ JOSEPH·Filed 2007·Application pending·0 cites
- 3149US2008149521A9Methods of stabilizing azithromycinPESACHOVICH MICHAEL·Filed 2006·Application pending·0 cites
- 3248US2010129431A1Idebenone composition for the treatment of neurological disordersALPHARX INC·Filed 2008·Application pending·0 cites
- 3347US2006241175A1Vehicle for topical delivery of anti-inflammatory compoundsSCHWARZ JOSEPH·Filed 2006·Application pending·0 cites
- 3444US2016000702A1Pharmaceutical composition for enhanced transmucosal adminstration of benzodiazepinesEASTGATE PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3544US2006222716A1Colloidal solid lipid vehicle for pharmaceutical useSCHWARZ JOSEPH·Filed 2005·Application pending·0 cites
- 3643US2020022386A1Method of preparation of cannabinoids containing beveragesPHARCON INC·Filed 2019·Application pending·0 cites
- 3742US2012297796A1Thin film peltier thermal light power barrier coolerSCHWARZ JOSEPH R·Filed 2011·Application pending·0 cites
- 3841US2013039978A1Medicinal compositions and method for treatment of urinary tract infectionsSCHWARZ JOSEPH·Filed 2012·Application pending·0 cites
- 3940US2009062244A1Pharmaceutical compositionSCHWARZ JOSEPH·Filed 2007·Application pending·0 cites
- 4040US2012034278A1Ophthalmic preparation containing menthyl ester of indomethacinSCHWARZ JOSEPH·Filed 2011·Application pending·0 cites
- 4139US2008287532A1Oxacyclopentene-2 derivativesSCHWARZ JOSEPH·Filed 2007·Application pending·0 cites
- 4237US2017281573A1Medicinal composition for enhanced delivery of triterpenesPHARCON INC·Filed 2017·Application pending·0 cites
- 4335US2016000803A1Pharmaceutical composition for transmucosal administration of benzodiazepinesEASTGATE PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4434US10568936B2Pharmaceutical composition for transmucosal delivery and methods for treating diabetes in a subject in need thereofEASTGATE PHARMACEUTICALS INC·Filed 2015·Granted Feb 25, 2020·0 cites·31 claims
- 4534US2020360341A1Indomethacin menthyl ester-based pharmaceutical compositions and their use as anti-inflammatory agentsOBSHESTVO S OGRANICHENNOI OTVETSTVENNOSTJU FORBOS”·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joseph Schwarz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →